A Biologically-validated HCV E1E2 Heterodimer Structural Model
Abstract The design of vaccine strategies and the development of drugs targeting the early stages of Hepatitis C virus (HCV) infection are hampered by the lack of structural information about its surface glycoproteins E1 and E2, the two constituents of HCV entry machinery. Despite the recent crystal...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2017
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/563bbbe9e5ee45d1a8b0876740226501 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|